First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study
一线纳武利尤单抗和瑞拉利单抗联合化疗治疗胃或胃食管交界处腺癌:II期RELATIVITY-060研究
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.23.01636
Hegewisch-Becker, Susanna; Mendez, Guillermo; Chao, Joseph; Nemecek, Radim; Feeney, Kynan; Van Cutsem, Eric; Al-Batran, Salah-Eddin; Mansoor, Wasat; Maisey, Nicholas; Pazo Cid, Roberto; Burge, Matthew; Perez-Callejo, David; Hipkin, R William; Mukherjee, Sourav; Lei, Ming; Tang, Hao; Suryawanshi, Satyendra; Kelly, Ronan J; Tebbutt, Niall C